摘要
背景:丹参具有不同的抗癌特性,这归因于其二萜和酚的含量。关于丹参成分的抗癌多样性和分子靶点没有全面的综述。 目的:研究丹参植物代谢物的多样性和分子靶点,负责预防和治疗癌症和肉瘤。 结果与结论:传统的治疗知识表明,丹参种类可用于开发抗癌药物。对丹参酮(Tan)IIA和隐丹参酮已经提出了许多担忧。一些丹参化合物干扰细胞周期,诱导肿瘤细胞凋亡或增强免疫活性,另一些则抑制增殖,侵袭,血管生成和转移,或逆转癌细胞的多药耐药性。丹参植物代谢产物调节Hanahan和Weinberg定义的大多数癌症标志。同一类植物代谢物可以通过多种途径发挥抗癌活性。已经揭示了一些植物代谢物的ADME / T性质和药物代谢动力学的外观。荧光探针是筛选来自Salvia植物代谢物的药物代谢酶/转运蛋白的底物,抑制剂或诱导剂的有力工具。 Omics平台将大大有助于从丹参植物中挖掘更多潜在有用的植物代谢物。更多的丹参植物在制药工业和临床癌症治疗中具有应用潜力。
关键词: 丹参,萜烯,酚类,抗癌多样性,组学,药物靶点。
Current Drug Targets
Title:Anticancer Drug Targets of Salvia Phytometabolites: Chemistry, Biology and Omics
Volume: 19 Issue: 1
关键词: 丹参,萜烯,酚类,抗癌多样性,组学,药物靶点。
摘要: Background: Salvia displays diverse anticancer properties, which are attributable to their diterpene and phenolic contents. There is no comprehensive review on the anticancer diversity and molecular targets of Salvia components.
Objective: We investigate the diversity and molecular targets of Salvia phytometabolites responsible for the prevention and treatment of cancer and sarcoma.
Results and Conclusion: Traditional therapeutic knowledge suggests that Salvia species can be used to develop anticancer drugs. Lots of concerns have been raised for tanshinone (Tan) IIA and cryptotanshinone. Some Salvia compounds disturb cell cycle and induce apoptosis of tumor cells or enhance immune activities, while others inhibit the proliferation, invasion, angiogenesis, and metastasis, or reverse the multi-drug resistance of cancer cells. Salvia phytometabolites regulate most cancer hallmarks defined by Hanahan and Weinberg. The same class of phytometabolite could exert the anticancer activity via multiple pathways. ADME/T properties and pharmacokinetic bebaviors of some phytometabolites have been revealed. Fluorescent probes are powerful tools for screening substrates, inhibitors or inducers of drug metabolizing enzymes/transporters from Salvia phytometabolites. Omics platform will greatly help mining more potentially useful phytometabolites from Salvia plants. More Salvia plants have application potential in pharmaceutical industry and clinical cancer therapy.
Export Options
About this article
Cite this article as:
Anticancer Drug Targets of Salvia Phytometabolites: Chemistry, Biology and Omics, Current Drug Targets 2018; 19 (1) . https://dx.doi.org/10.2174/1389450117666161207141020
DOI https://dx.doi.org/10.2174/1389450117666161207141020 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ligand-Targeted Liposomal Therapies of Neuroblastoma
Current Medicinal Chemistry Exploring Protein-Protein Interactions with Synthetic Peptide Arrays
Mini-Reviews in Organic Chemistry Cellular Functions of Vaults and their Involvement in Multidrug Resistance
Current Drug Targets Studies on the Mechanism of Action of Benzamide Riboside: A Novel Inhibitor of IMP Dehydrogenase
Current Medicinal Chemistry Antioxidants and its Properties as Affected by Extrusion Process: A Review
Recent Patents on Food, Nutrition & Agriculture Accuracy of a Topical PET/CT Scanner on SUV Measurements of Small Volumes SUV
Current Medical Imaging High-Throughput Functional Genomic Methods to Analyze the Effects of Dietary Lipids
Current Pharmaceutical Biotechnology The Development of PDGF Receptor Inhibitors for the Treatment of Glioma: A Review
Letters in Drug Design & Discovery Gene Therapy (Part II)
Current Gene Therapy Fungal Proteins with Antiproliferative and Anticancer Activities
Protein & Peptide Letters Induction of Abscopal Anti-Tumor Immunity and Immunogenic Tumor Cell Death by Ionizing Irradiation - Implications for Cancer Therapies
Current Medicinal Chemistry Targeting Ion Channels for New Strategies in Cancer Diagnosis and Therapy
Current Clinical Pharmacology Antisense Oligonucleotide Drug Design
Current Pharmaceutical Design Polymeric Carriers for Gene Delivery: Chitosan and Poly(amidoamine) Dendrimers
Current Pharmaceutical Design Combining Cytotoxic and Immune-Mediated Gene Therapy to Treat Brain Tumors
Current Topics in Medicinal Chemistry Clinical Application of Sorafenib for Treating Hepatocellular Carcinoma and Beyond
Clinical Cancer Drugs Brain Targeted Drug Delivery: Factors, Approaches and Patents
Recent Patents on Nanomedicine Patents in the Era of Genomics: An Overview
Recent Patents on DNA & Gene Sequences Innate Immunity and Intracellular Trafficking: Insights for Novel Anti- HIV-1 Therapeutics
Current Pharmacogenomics Natural Flora and Anticancer Regime: Milestones and Roadmap
Anti-Cancer Agents in Medicinal Chemistry